Compugen Ltd. (CGEN) - NASDAQ
  • Tue, May 10, 7:10 AM
    • Compugen (NASDAQ:CGEN): Q1 EPS of -$0.17 misses by $0.02.
    • Revenue of $0.1M (-80.4% Y/Y) misses by $0.54M.
    • Press Release
    | Tue, May 10, 7:10 AM
  • Tue, Feb. 9, 8:40 AM
    • Compugen (CGEN) Q4 results: Revenues: $8.3M (+25.8%); Operating Expense: $8M (+19.4%); Operating Loss: ($0.7M) (+36.4%); Net Loss: ($0.5M) (+66.7%); Loss Per Share: ($0.01) (+66.7%).
    • FY2015 results: Revenues: $9.3M (-25.0%); Operating Expense: $28.6M (+33.6%); Operating Loss: ($20.9M) (-69.9%); Net Loss: ($20.2M) (-82.0%); Loss Per Share: ($0.40) (-53.8%); Quick Assets: $81.4M (+11.1%).
    • No guidance given.
    | Tue, Feb. 9, 8:40 AM
  • Tue, Feb. 9, 7:12 AM
    • Compugen (NASDAQ:CGEN): Q4 EPS of -$0.01 beats by $0.10.
    • Revenue of $8.31M (+26.9% Y/Y) beats by $4.98M.
    • Press Release
    | Tue, Feb. 9, 7:12 AM
  • Nov. 3, 2015, 10:52 AM
    • Compugen (CGEN -2.6%) Q3 results: Revenues: $0.2M (-88.2%); COGS: $0.2M (-71.4%); Operating Expense: $6.9M (+23.2%); Operating Loss: ($6.9M) (-50.0%); Net Loss: ($6.7M) (-24.1%); Loss Per Share: ($0.13) (-18.2%); Quick Assets: $74.3M (+1.4%).
    • No guidance giiven.
    | Nov. 3, 2015, 10:52 AM
  • Nov. 3, 2015, 7:08 AM
    • Compugen (NASDAQ:CGEN): Q3 EPS of -$0.13 beats by $0.02.
    • Revenue of $0.23M (-86.6% Y/Y) misses by $0.92M.
    | Nov. 3, 2015, 7:08 AM
  • Aug. 4, 2015, 7:14 AM
    • Compugen (NASDAQ:CGEN): Q2 EPS of -$0.14 misses by $0.01.
    • Revenue of $0.22M (-88.8% Y/Y) misses by $1.58M.
    | Aug. 4, 2015, 7:14 AM
  • May 5, 2015, 7:42 AM
    • Compugen (NASDAQ:CGEN): Q1 EPS of -$0.12 beats by $0.01.
    • Revenue of $0.51M (-76.1% Y/Y) misses by $0.97M.
    | May 5, 2015, 7:42 AM
  • Feb. 10, 2015, 7:16 AM
    • Compugen (NASDAQ:CGEN): Q4 EPS of -$0.03 beats by $0.08.
    • Revenue of $6.55M (+268.0% Y/Y) beats by $2.85M.
    • Shares are up 8% premarket on increased volume.
    | Feb. 10, 2015, 7:16 AM
  • Feb. 3, 2015, 7:45 AM
    • Compugen (NASDAQ:CGEN) will report Q4 and full-year results on February 10 before the open. The conference call will begin at 10:00 am ET.
    • Consensus views for Q4 and 2014 are losses per share of ($0.11) and ($0.31) on revenues of $3.7M and $7.6M, respectively.
    | Feb. 3, 2015, 7:45 AM
  • Oct. 29, 2014, 1:04 PM
    • Compugen (CGEN -7.7%) Q3 results: Revenues: $1.7M (+6.2%); Gross Profit: $1M (+900.0%); Operating Expense: $5.6M (+24.4%); Operating Loss: ($4.6M) (-4.5%); Net Loss: ($5.4M) (-14.9%); Loss Per Share: ($0.11) (+8.3%); Quick Assets: $107.4M (+129.5%).
    • No guidance given.
    | Oct. 29, 2014, 1:04 PM
  • Oct. 29, 2014, 7:17 AM
    • Compugen (NASDAQ:CGEN): Q3 EPS of -$0.11 in-line.
    • Revenue of $1.72M (+8.2% Y/Y) misses by $0.18M.
    | Oct. 29, 2014, 7:17 AM
  • Oct. 22, 2014, 11:37 AM
    • Compugen (CGEN -0.1%) will report Q3 results on the morning of October 29. The conference call will begin at 10:00 am ET.
    • Consensus view is a loss of ($0.11) per share on revenues of $1.9M.
    | Oct. 22, 2014, 11:37 AM
  • Aug. 6, 2014, 7:20 AM
    • Compugen (NASDAQ:CGEN) Q2 results: Revenues: $2.0M (+792.7%); Gross Profit: $1.1M (+999%); Operating Expenses: $4.4M (-5.0%); Operating Loss: ($3.3M) (+29.7%); Net Loss: ($2.3M) (+25.7%); Loss Per Share: ($0.05) (+37.5%); Quick Assets: $113.3M (+142.1%).
    • No Guidance given.
    | Aug. 6, 2014, 7:20 AM | 1 Comment
  • May 19, 2014, 7:09 AM
    • Compugen (CGEN): Q1 EPS of -$0.04 beats by $0.06.
    • Revenue of $2.1M (+1231% Y/Y) beats by $0.26M.
    | May 19, 2014, 7:09 AM
  • Feb. 11, 2014, 7:24 AM
    • Compugen Ltd. (CGEN): Q4 EPS of $-0.09 beats by $0.03.
    • Revenue of $1.8M (+1284.6% Y/Y) beats by $1M.
    | Feb. 11, 2014, 7:24 AM
Company Description
Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli... More
Sector: Healthcare
Industry: Biotechnology
Country: United States